We validated a previously reported cancer-associated transcript POU6F2-AS2 in plasma and serum samples from lung cancer, pancreatic ductal adenocarcinoma, malignant melanoma, and bladder cancer samples. Here, POU6F2 is linked to pancreatic ductal adenocarcinoma.